UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Diluted EPS, 2025
- $27.86
- YoY, 2025
- +13.1%
- 5-year CAGR
- +19.3%
- 10-year CAGR
- +8.2%
Diluted EPS
Diluted EPS by fiscal year
| Period | EPS | YoY |
|---|---|---|
| 2025 | $27.86 | +13.1% |
| 2024 | $24.64 | +24.4% |
| 2023 | $19.81 | +32.1% |
| 2022 | $15.00 | +49.1% |
| 2021 | $10.06 | −12.8% |
| 2020 | $11.54 | — |
| 2019 | −$2.39 | — |
| 2018 | $13.39 | +43.8% |
| 2017 | $9.31 | −39.0% |
| 2016 | $15.25 | +19.9% |
| 2015 | $12.72 | +102.5% |
| 2014 | $6.28 | +91.5% |
| 2013 | $3.28 | −42.6% |
| 2012 | $5.71 | +55.6% |
| 2011 | $3.67 | +106.2% |
| 2010 | $1.78 | +408.6% |
| 2009 | $0.35 | — |
| 2008 | −$1.08 | — |